SeekingAlpha · Aug 8, 2026
Altria: A Buy After The Correction
Altria payout ratio has fallen to 89%, supporting sustainable, inflation-matching dividend growth, though limited room exists. Learn why MO stock is a buy.
NASDAQ · IMBBY
Consumer Defensive · Tobacco
$34.87
Up+$0.05 (+0.14%)
Updated Aug 19, 2026, 4:49 AM
SID Score
7.4/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
IMBBY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning IMBBY.
IMBBY research
Company profile and research snapshot.
IMPERIAL BRANDS PLC ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 28, 2026 | Jefferies | Buy | — |
| May 13, 2026 | RBC Capital Markets | Sector Perform | — |
| May 13, 2026 | Jefferies | Buy | — |
| May 13, 2026 | Deutsche | Buy | — |
| May 11, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
SeekingAlpha · Aug 8, 2026
Altria payout ratio has fallen to 89%, supporting sustainable, inflation-matching dividend growth, though limited room exists. Learn why MO stock is a buy.
SeekingAlpha · Jul 31, 2026
British American Tobacco is rated a Buy; transitioning into next-generation nicotine products is key. Read more on BTI stock here.
SeekingAlpha · Jul 17, 2026
Imperial Brands (IMBBY) looks undervalued at 8.6x forward P/E with a 5.6% yield; pricing power and NGP growth support EPS.
SeekingAlpha · Jun 4, 2026
Imperial Brands PLC (IMBBY) 23rd annual dbAccess Global Consumer Conference June 1, 2026 8:00 PM EDTCompany ParticipantsLukas Paravicini - CEO &...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IMBBY.
No results
No recent SID articles mention IMBBY.